DK154654C - Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf

Info

Publication number
DK154654C
DK154654C DK552476A DK552476A DK154654C DK 154654 C DK154654 C DK 154654C DK 552476 A DK552476 A DK 552476A DK 552476 A DK552476 A DK 552476A DK 154654 C DK154654 C DK 154654C
Authority
DK
Denmark
Prior art keywords
acceptable
alkancarboxyl
oaa
desoxy
glucosyl
Prior art date
Application number
DK552476A
Other languages
Danish (da)
English (en)
Other versions
DK552476A (da
DK154654B (da
Inventor
Gerhard Baschang
Albert Hartmann
Jaroslav Stanek
Alex Sele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK552476A publication Critical patent/DK552476A/da
Publication of DK154654B publication Critical patent/DK154654B/da
Application granted granted Critical
Publication of DK154654C publication Critical patent/DK154654C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK552476A 1975-12-10 1976-12-09 Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf DK154654C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1604275 1975-12-10
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (3)

Publication Number Publication Date
DK552476A DK552476A (da) 1977-06-11
DK154654B DK154654B (da) 1988-12-05
DK154654C true DK154654C (da) 1989-05-08

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK552476A DK154654C (da) 1975-12-10 1976-12-09 Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf

Country Status (30)

Country Link
JP (1) JPS5273820A (ru)
AR (2) AR224091A1 (ru)
AT (1) AT365607B (ru)
AU (1) AU508764B2 (ru)
BE (1) BE849214A (ru)
CA (1) CA1262400A (ru)
CH (2) CH613709A5 (ru)
CS (4) CS205028B2 (ru)
DD (1) DD129781A5 (ru)
DE (1) DE2655500A1 (ru)
DK (1) DK154654C (ru)
ES (2) ES454118A1 (ru)
FI (1) FI64164C (ru)
FR (1) FR2361902A1 (ru)
GB (1) GB1570625A (ru)
GR (1) GR61647B (ru)
HK (1) HK32883A (ru)
HU (1) HU177970B (ru)
IE (1) IE44190B1 (ru)
IL (1) IL51076A (ru)
MY (1) MY8400123A (ru)
NL (1) NL7613666A (ru)
NO (1) NO144850C (ru)
NZ (1) NZ182837A (ru)
PL (4) PL112672B1 (ru)
PT (1) PT65946B (ru)
SE (1) SE445923B (ru)
SG (1) SG11083G (ru)
SU (3) SU660589A3 (ru)
ZA (1) ZA767333B (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH636887A5 (en) * 1976-04-26 1983-06-30 Syntex Inc Process for the preparation of novel immunological adjuvant compounds
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
DE3070457D1 (en) * 1979-10-02 1985-05-15 Ciba Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (ru) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
US7838685B2 (en) 2005-04-27 2010-11-23 Shinji Takeoka Cationic amino acid type lipid
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2017098529A1 (en) 2015-12-10 2017-06-15 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
CA3072735A1 (en) 2017-08-21 2019-02-28 Celgene Corporation Processes for the preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
ZA767333B (en) 1977-11-30
IE44190L (en) 1977-06-10
DE2655500A1 (de) 1977-06-23
FI763541A (ru) 1977-06-11
ES465514A1 (es) 1978-09-16
IL51076A0 (en) 1977-02-28
FR2361902A1 (fr) 1978-03-17
SE445923B (sv) 1986-07-28
PT65946B (en) 1978-06-14
DD129781A5 (de) 1978-02-08
NO144850C (no) 1981-11-25
NO764191L (ru) 1977-06-13
CS205027B2 (en) 1981-04-30
CS205028B2 (en) 1981-04-30
SE7613851L (sv) 1977-06-11
FR2361902B1 (ru) 1980-11-07
MY8400123A (en) 1984-12-31
JPS5273820A (en) 1977-06-21
AT365607B (de) 1982-02-10
ATA909276A (de) 1981-06-15
BE849214A (fr) 1977-06-09
AR220686A1 (es) 1980-11-28
IE44190B1 (en) 1981-09-09
NZ182837A (en) 1978-07-28
HK32883A (en) 1983-09-02
DK552476A (da) 1977-06-11
AU508764B2 (en) 1980-04-03
PT65946A (en) 1977-01-01
PL194291A1 (pl) 1978-10-23
DE2655500C2 (ru) 1988-12-22
JPS638118B2 (ru) 1988-02-19
SU660589A3 (ru) 1979-04-30
PL112672B1 (en) 1980-10-31
ES454118A1 (es) 1978-03-01
PL110787B1 (en) 1980-07-31
PL110353B1 (en) 1980-07-31
NO144850B (no) 1981-08-17
AU2042276A (en) 1978-06-15
IL51076A (en) 1980-09-16
CH614718A5 (en) 1979-12-14
AR224091A1 (es) 1981-10-30
CA1262400A (en) 1989-10-17
HU177970B (en) 1982-02-28
FI64164B (fi) 1983-06-30
SG11083G (en) 1983-09-16
PL110794B1 (en) 1980-07-31
CS205025B2 (en) 1981-04-30
CH613709A5 (en) 1979-10-15
CS205026B2 (en) 1981-04-30
NL7613666A (nl) 1977-06-14
FI64164C (fi) 1983-10-10
SU1060118A3 (ru) 1983-12-07
DK154654B (da) 1988-12-05
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
SU747430A3 (ru) 1980-07-23

Similar Documents

Publication Publication Date Title
DK154654C (da) Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK152495C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf
DK346276A (da) Fremgangsmade til fremstilling af alfa-phenylbenzylidenderivater af aminosyrer
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK151330C (da) Analogifremgangsmaade til fremstilling af aminoalkoholderivater eller farmaceutiske acceptable salte deraf
DK154950C (da) Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK149230C (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK150196C (da) Analogifremgangsmaade til fremstilling af 0-(3-amino-2-hydroxypropyl)-amidoximderivater eller farmaceutisk acceptable salte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK155433C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf
DK144033C (da) Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf
DK152208C (da) Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK143278C (da) Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK149093C (da) Analogifremgangsmaade til fremstilling af pentapeptidderivater eller farmaceutisk acceptable salte deraf
DK148019C (da) Analogifremgangsmaade til fremstilling af 2-pyridylaminobenzoesyrer eller farmaceutisk acceptable salte deraf
DK147577C (da) Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed